You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 6, 2025

Drug Price Trends for NDC 00113-2023


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 00113-2023

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for the Pharmaceutical Industry: A Focus on NDC 00113-2023

Introduction

The pharmaceutical industry is a complex and dynamic sector, influenced by a myriad of factors including regulatory changes, technological advancements, and market dynamics. This article will delve into the market analysis and price projections for pharmaceutical products, with a specific focus on the National Drug Code (NDC) 00113-2023. We will explore the current trends, pricing mechanisms, and future projections that shape the industry.

Understanding the National Drug Code (NDC)

The NDC is a unique, three-segment number that serves as the FDA’s identifier for drugs. It consists of a labeler code, product code, and package code, providing a universal product identifier for human drugs[1][5].

Market Trends in the Pharmaceutical Industry

Continued Dominance of Small Molecule Drugs

In 2024, small molecule drugs are expected to maintain their dominance in the pharmaceutical market. This is partly due to the outsourcing of drug development and manufacturing, which helps in reducing costs and improving efficiency[3].

Growing Adoption of Biologics

Biologics are gaining traction, driven by advancements in technology and regulatory shifts. These biological products are complex and often more expensive than traditional small molecule drugs, which can impact pricing dynamics[3].

Personalized Medicine

The use of AI in pharmaceuticals is driving the demand for personalized medicine. This trend is expected to grow, leading to more targeted and potentially more expensive treatments[3].

Pricing Dynamics in the Pharmaceutical Industry

List Price Increases

Drug manufacturers can change the list prices of their drugs at any time after launch. From January 2022 to January 2023, over 4,200 drug products experienced price increases, with an average increase of 15.2% or $590 per drug product. This trend indicates that price increases are a common practice and can significantly impact the affordability of drugs[2].

Impact of Inflation and Market Events

Price increases often exceed the rate of inflation. For instance, multi-source drugs tend to have higher percentage price increases, while single-source drugs experience larger absolute dollar increases. These changes are influenced by various market events, such as the utilization of weight-loss drugs and insulin price decreases[2][4].

Specific Analysis for NDC 00113-2023

To analyze the market and price projections for a specific NDC like 00113-2023, several factors need to be considered:

Product Identification

The NDC 00113-2023 identifies a specific drug product, including its labeler, product, and package details. This information is crucial for understanding the product's market position and pricing history[1][5].

Historical Price Trends

Reviewing historical price data for the NDC 00113-2023 can provide insights into past price increases and decreases. This data can be obtained from the FDA's NDC Directory and other market analytics tools[2].

Market Competition

The level of competition for the drug product identified by NDC 00113-2023 is a significant factor. If the drug is a single-source product, it may experience larger absolute dollar price increases compared to multi-source drugs[2].

Regulatory and Market Events

Changes in regulatory policies, patent expirations, and significant market events such as the introduction of new treatments or changes in prescribing patterns can all impact the pricing of the drug[3][4].

Price Projections

Average Wholesale Price (AWP) Increases

Commercial payers can expect an average wholesale price (AWP) increase of 11% to 19% annually from 2022 to 2024, influenced by factors such as drug mix, patent losses, and manufacturer price changes[4].

Specific Projections for NDC 00113-2023

Given the general trend of price increases exceeding inflation rates, it is likely that the drug product identified by NDC 00113-2023 will experience a price increase. However, the exact percentage or dollar amount will depend on the specific market dynamics and historical pricing data for this product.

Challenges and Opportunities

Affordability and Access

High prescription drug prices create significant affordability challenges for patients, healthcare payers, employers, and taxpayers. Addressing these challenges while ensuring access to necessary medications is a critical issue for the industry[2].

Technological Advancements

Advancements in AI and other technologies offer opportunities for improved drug discovery, personalized medicine, and process optimization. These innovations can lead to more effective treatments but may also increase costs[3].

Regulatory Compliance

Pharmaceutical companies must navigate complex regulatory requirements, including the submission of drug product information to the FDA and compliance with the Drug Listing Act. Non-compliance can result in products not being included in the NDC Directory[1][5].

Key Takeaways

  • NDC Importance: The National Drug Code is a critical identifier for drug products, providing a universal product identifier.
  • Pricing Trends: Drug prices are increasing, often exceeding inflation rates, with significant variations between single-source and multi-source drugs.
  • Market Dynamics: The pharmaceutical industry is influenced by technological advancements, regulatory changes, and market events such as the introduction of new treatments.
  • Affordability: High drug prices pose significant challenges for affordability and access.
  • Regulatory Compliance: Compliance with FDA regulations is essential for drug products to be listed and marketed.

FAQs

Q: What is the National Drug Code (NDC) and its significance? A: The NDC is a unique, three-segment number that serves as the FDA’s identifier for drugs, providing a universal product identifier for human drugs[1][5].

Q: How often can drug manufacturers change the list prices of their drugs? A: Drug manufacturers can change the list prices of their drugs at any time after launch[2].

Q: What factors influence the pricing of pharmaceutical products? A: Pricing is influenced by factors such as market competition, regulatory changes, technological advancements, and significant market events[2][3][4].

Q: How do single-source and multi-source drugs differ in terms of price increases? A: Single-source drugs tend to have larger absolute dollar price increases, while multi-source drugs experience higher percentage price increases[2].

Q: What role does AI play in the pharmaceutical industry? A: AI is driving the demand for personalized medicine and process optimization, potentially leading to more targeted and expensive treatments[3].

Sources

  1. FDA's National Drug Code Directory - FDA
  2. Changes in the List Prices of Prescription Drugs, 2017-2023 - ASPE
  3. Top 12 Pharmaceutical Industry Trends in 2024 - Global Pharma Tek
  4. Commercial Drug Trends 2023 - Milliman
  5. National Drug Code Database Background Information - FDA

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.